TITLE

TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis

AUTHOR(S)
Arkwright, Peter D.; Laurie, Steven; Super, Maurice; Pravica, Vera; J. Schwarz, Martin; Webb, A. Kevin; Hutchinson, Ian V.
PUB. DATE
June 2000
SOURCE
Thorax;Jun2000, Vol. 55 Issue 6, p459
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67206395

 

Related Articles

  • Author's response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Taylor-Robinson, David; Whitehead, Margaret; Diderichsen, Finn; Olesen, Hanne Vebert; Pressler, Tania; Smyth, Rosalind; Diggle, Peter // Thorax;Mar2013, Vol. 68 Issue 3, p294 

    A response from the author of the article "Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study" in the 2012 issue, which discusses repeated measurement of lung function in patients with cystic fibrosis, is presented.

  • Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients. Melotti, Paola; Mafficini, Andrea; Lebecque, Patrick; Ortombina, Myriam; Leal, Teresinha; Pintani, Emily; Pepermans, Xavier; Sorio, Claudio; Assael, Baroukh Maurice // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Macrophage migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine sustaining the acute response to gram–negative bacteria and a regulatory role for MIF in Cystic Fibrosis has been suggested by the presence of a functional, polymorphic, four-nucleotide repeat in this gene's...

  • Improved survival in cystic fibrosis patients with severely impaired lung function. Narwani, Vishal // Thorax;Feb2012, Vol. 67 Issue 2, p138 

    The article presents information on a study evaluating the threshold of survival of cystic fibrosis patients with severely damaged lung function.

  • Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan. Hsieh, Meng-Heng; Chou, Pai-Chien; Chou, Chun-Liang; Ho, Shu-Chuan; Joa, Wen-Ching; Chen, Li-Fei; Sheng, Te-Fang; Lin, Horng-Chyuan; Wang, Tsai-Yu; Chang, Po-Jui; Wang, Chun-Hua; Kuo, Han-Pin // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Objectives: Bronchiectasis is characterized by an irreversible dilatation of bronchi and is associated with lung fibrosis. MMP-1 polymorphism may alter its transcriptional activity, and differentially modulate bronchial destruction and lung fibrosis. Design: To investigate the association of...

  • Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Sims, Erika J.; Green, Michael W.; Mehta, Anil // Diabetes Care;Jul2005, Vol. 28 Issue 7, p1581 

    Objective: Although cystic fibrosis-related diabetes (CFRD) is associated with decreased lung function, sex is not known to influence CFRD. However, compared with male subjects with cystic fibrosis, female subjects with cystic fibrosis have increased morbidity. This study examines...

  • Emerging issues in cystic fibrosis.  // Thorax;Dec2004 Supplement, Vol. 59, p12 

    The article presents information on several abstracts of papers related to cystic fibrosis (CF). Until recently there have been few case reports of acute renal failure (ARF) in patients with CF. The registry of the Nottingham regional pediatric renal unit shows no cases of ARF in a patient with...

  • Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Texereau J; Marullo S; Hubert D; Coste J; Dusser D J; Dall'Ava-Santucci J; Dinh-Xuan A T // Thorax;Feb2004, Vol. 59 Issue 2, p156 

    BACKGROUND: The severity of lung disease varies widely in patients with cystic fibrosis (CF) who have the same type of mutations of the cystic fibrosis transmembrane regulator (CFTR) gene, suggesting involvement of "modifier" genes. The nitric oxide synthase 1 (NOS1) gene is a candidate for this...

  • Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Gu, YuanYuan; Harley, Isaac T. W.; Henderson, Lindsay B.; Aronow, Bruce J.; Vietor, Ilja; Huber, Lukas A.; Harley, John B.; Kilpatrick, Jeffrey R.; Langefeld, Carl D.; Williams, Adrienne H.; Jegga, Anil G.; Chen, Jing; Wills-Karp, Marsha; Arshad, S. Hasan; Ewart, Susan L.; Thio, Chloe L.; Flick, Leah M.; Filippi, Marie-Dominique; Grimes, H. Leighton; Drumm, Mitchell L. // Nature;4/23/2009, Vol. 458 Issue 7241, p1039 

    Lung disease is the major cause of morbidity and mortality in cystic fibrosis, an autosomal recessive disease caused by mutations in CFTR. In cystic fibrosis, chronic infection and dysregulated neutrophilic inflammation lead to progressive airway destruction. The severity of cystic fibrosis lung...

  • Pregnancy outcomes in cystic fibrosis: a 10-year experience from a UK centre. Renton, M; Priestley, L; Bennett, L; Mackillop, L; Chapman, SJ // Obstetric Medicine (1753-495X);Jun2015, Vol. 8 Issue 2, p99 

    The article presents a study examining pregnancy outcomes in cystic fibrosis patients for more than 10-year period from an adult cystic fibrosis centre in Great Britain. The study used respiratory and obstetric records of pregnancies during 2003-2013. Results showed that a decline in lung...

  • Following Nero: fiddle while Rome burns, or is there a better way? Bush, Andrew; Pavord, Ian // Thorax;May2011, Vol. 66 Issue 5, p367 

    The author comments on the use of the term exacerbation in describing severity of asthma or chronic obstructive pulmonary disease in relation to a proposal to discard the term in favor of the phrase lung attack. The author criticizes the generally accepted view of exacerbation and discusses how...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics